uspto-grants-2005_02 · 10.6084/m9.figshare.5104873.v1 · US06858603B2
查看IDENTITY
结构与身份
- 标准SMILES
- CN(C)CC(=O)O
- InChIKey
- FFDGPVCHZBVARC-UHFFFAOYSA-N
- 分子式
- C4H9NO2
- 平均分子量
- 103.12 g/mol
- 单同位素质量
- 103.06332853
COMPUTED
结构计算性质
- XLogP
- -2.9
- 极性表面积
- 40.5 Ų
- 氢键供体
- 1
- 氢键受体
- 3
- 可旋转键
- 2
- 重原子
- 7
- 形式电荷
- 0
- 复杂度
- 70
PROPERTIES
实验与物化性质
LogP
-2.91
-2.91
Boiling Point
63.9
Melting Point
185.5
185.5 °C
Physical Description
Solid
Dissociation Constants
2.04
Collision Cross Section
119.7 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
116 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine]
123.1 Ų [M+H]+
GHS
GHS分类
GHS Classification
This chemical does not meet GHS hazard criteria for 53.2% (58 of 109) of all reports.
Warning
H302 (46.8%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 109 reports by companies from 4 notifications to the ECHA C&L Inventory.;Reported as not meeting GHS hazard criteria per 58 of 109 reports by companies.;There are 3 notifications provided by 51 of 109 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
HAZARDS
危害信息
Regulatory Information
PMN - indicates a commenced PMN (Pre-Manufacture Notices) substance.
Status: Active Update: 22-05-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/19838
Dimethylglycine: Non hazardous
Hazard Classes and Categories
Acute Tox. 4 (46.8%)
REGULATORY
法规信息
Regulatory Information
PMN - indicates a commenced PMN (Pre-Manufacture Notices) substance.
Status: Active Update: 22-05-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/19838
Dimethylglycine: Non hazardous
PHARMACOLOGY
药理信息
Tissue Locations
Kidney;Liver;Placenta
Cellular Locations
Cytoplasm;Mitochondria
Metabolite Pathways
3-Phosphoglycerate dehydrogenase deficiency;Cystathionine Beta-Synthase Deficiency;Dihydropyrimidine Dehydrogenase Deficiency (DHPD);Dimethylglycine Dehydrogenase Deficiency;Dimethylglycine Dehydrogenase Deficiency;Glycine N-methyltransferase Deficiency;Glycine, serine and threonine metabolism;Glycine, serine and threonine metabolism;Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type;Hyperglycinemia, non-ketotic;Total 18 pathways, visit the HMDB page for details
USES
用途与制造
General Manufacturing Information
Glycine, N,N-dimethyl-: ACTIVE
ALIASES
名称与别名
REACTIONS
相关反应
uspto-grants-2008_09 · 10.6084/m9.figshare.5104873.v1 · US07419988B2
查看uspto-grants-2013_09 · 10.6084/m9.figshare.5104873.v1 · US08536180B2
查看uspto-grants-2004_03 · 10.6084/m9.figshare.5104873.v1 · US06713464B1
查看uspto-grants-2016_09 · 10.6084/m9.figshare.5104873.v1 · US09440973B2
查看uspto-grants-2016_09 · 10.6084/m9.figshare.5104873.v1 · US09440972B2
查看uspto-grants-2016_09 · 10.6084/m9.figshare.5104873.v1 · US09440972B2
查看uspto-grants-2016_09 · 10.6084/m9.figshare.5104873.v1 · US09440972B2
查看